Fredun Pharma

71
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
2,374.95
10.75 (0.45%)
BSENSE

May 08

BSE+NSE Vol: 21.54 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
453.00
220.00
233.00
105.91%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
453.00
220.00
233.00
105.91%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
-3.00
9.00
300.00%
Raw Materials Consumed
321.00
123.00
198.00
160.98%
Power & Fuel Cost
4.00
4.00
0.00
0.00%
Employee Cost
22.00
18.00
4.00
22.22%
Operating Expenses
14.00
17.00
-3.00
-17.65%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
11.00
-6.00
-54.55%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
401.00
188.00
213.00
113.30%
Operating Profit (PBDIT) excl Other Income
52.00
31.00
21.00
67.74%
Other Income
2.00
6.00
-4.00
-66.67%
Operating Profit (PBDIT)
55.00
37.00
18.00
48.65%
Interest
22.00
4.00
18.00
450.00%
Profit before Depriciation and Tax
32.00
32.00
0.00
0.00%
Depreciation
4.00
7.00
-3.00
-42.86%
Profit Before Taxation & Exceptional Items
28.00
25.00
3.00
12.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28.00
20.00
8.00
40.00%
Provision for Tax
7.00
5.00
2.00
40.00%
Profit After Tax
20.00
15.00
5.00
33.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
43.00
82.00
-39.00
-47.56%
Profit Available for appropriations
64.00
97.00
-33.00
-34.02%
Appropriations
64.00
97.00
-33.00
-34.02%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
44.83
15.29
29.54
193.20%
Profit And Loss - Net Sales
Net Sales 453.82 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.35% vs 26.75% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 38.61% vs 36.74% in Mar 2024

Profit And Loss - Interest
Interest 22.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 63.93% vs 47.07% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 20.81 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.18% vs 44.57% in Mar 2024